Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Dose Response Study of Patients With Erythematous Rosacea
This study has been completed.
Study NCT01186068 Information provided by Vicept Therapeutics, Inc.
First Received on August 17, 2010. Last Updated on November 22, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Erythematous (Type One) Rosacea
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial
Vicept Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers